{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:08:20Z","timestamp":1782958100657,"version":"3.54.5"},"reference-count":72,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["bloodreviews.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.blre.2014.03.001","type":"journal-article","created":{"date-parts":[[2014,3,23]],"date-time":"2014-03-23T12:01:52Z","timestamp":1395576112000},"page":"95-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Desmopressin in treatment of haematological disorders and in prevention of surgical bleeding"],"prefix":"10.1016","volume":"28","author":[{"given":"Peter J.","family":"Svensson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.F.","family":"Bergqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian Vinter","family":"Juul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Berntorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.blre.2014.03.001_bb0005","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1046\/j.1538-7836.2003.00197.x","article-title":"Desmopressin (DDAVP) induces NO production in human endothelial cells via V2 receptor- and cAMP-mediated signaling","volume":"1","author":"Kaufmann","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"2 Pt 1","key":"10.1016\/j.blre.2014.03.001_bb0010","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0895-7061(98)00230-1","article-title":"V2-receptor-mediated relaxation of human renal arteries in response to desmopressin","volume":"12","author":"Medina","year":"1999","journal-title":"Am J Hypertens"},{"issue":"1","key":"10.1016\/j.blre.2014.03.001_bb0015","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1172\/JCI9516","article-title":"Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP","volume":"106","author":"Kaufmann","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2014.03.001_bb0020","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0887-7963(91)70200-9","article-title":"DDAVP \u2014 the multipotent drug in patients with coagulopathies","volume":"5","author":"Schulman","year":"1991","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.blre.2014.03.001_bb0025","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1055\/s-0037-1616043","article-title":"Regulated secretion in endothelial cells: biology and clinical implications","volume":"86","author":"Datta","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2014.03.001_bb0030","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.1073\/pnas.92.16.7450","article-title":"Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin","volume":"92","author":"Frenette","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.blre.2014.03.001_bb0035","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3109\/09537104.2013.767442","article-title":"Desmopressin (DDAVP) improves recruitment of activated platelets to collagen but simultaneously increases platelet endothelial interactions in vitro","volume":"25","author":"Calmer","year":"2014","journal-title":"Platelets"},{"issue":"4","key":"10.1016\/j.blre.2014.03.001_bb0040","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1055\/s-0038-1646050","article-title":"Intranasal and intravenous administration of desmopressin: effect on F VIII\/vWF, pharmacokinetics and reproducibility","volume":"58","author":"Lethagen","year":"1987","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.blre.2014.03.001_bb0045","doi-asserted-by":"crossref","first-page":"6","DOI":"10.7326\/0003-4819-103-1-6","article-title":"Response of patients with mild and moderate hemophilia A and von Willebrand's disease to treatment with desmopressin","volume":"103","author":"De la Fuente","year":"1985","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.blre.2014.03.001_bb0050","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1182\/blood.V72.5.1449.1449","article-title":"Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders","volume":"72","author":"Mannucci","year":"1988","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.blre.2014.03.001_bb0055","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0887-7963(91)70200-9","article-title":"DDAVP\u2014the multipotent drug in patients with coagulopathies","volume":"5","author":"Schulman","year":"1991","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.blre.2014.03.001_bb0060","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2141.1975.tb00521.x","article-title":"Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs","volume":"30","author":"Mannucci","year":"1975","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.blre.2014.03.001_bb0065","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1055\/s-0031-1281034","article-title":"Nordic Haemophilia Council's practical guidelines on diagnosis and management of von Willebrand disease","volume":"37","author":"Lassila","year":"2011","journal-title":"Semin Thromb Hemost"},{"issue":"7","key":"10.1016\/j.blre.2014.03.001_bb0070","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra040403","article-title":"Treatment of von Willebrand's disease","volume":"351","author":"Mannucci","year":"2004","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.blre.2014.03.001_bb0075","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1182\/blood.V90.7.2515","article-title":"Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20years","volume":"90","author":"Mannucci","year":"1997","journal-title":"Blood"},{"issue":"48","key":"10.1016\/j.blre.2014.03.001_bb0080","first-page":"4155","article-title":"Desmopressin\u2014an effective agent in many hemorrhagic disorders","volume":"89","author":"Lethagen","year":"1992","journal-title":"Lakartidningen"},{"issue":"6","key":"10.1016\/j.blre.2014.03.001_bb0085","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/bjs.1800800616","article-title":"Use of desmopressin to prevent bleeding complications in patients treated with aspirin","volume":"80","author":"Flordal","year":"1993","journal-title":"Br J Surg"},{"issue":"5","key":"10.1016\/j.blre.2014.03.001_bb0090","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.athoracsur.2011.01.052","article-title":"Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion","volume":"91","author":"Steinlechner","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.blre.2014.03.001_bb0095","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2257.1984.tb00548.x","article-title":"Evaluation of the effectiveness of DDAVP in surgery and bleeding episodes in haemophilia and von Willebrand's disease. A study on 43 patients","volume":"6","author":"Mariana","year":"1984","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.blre.2014.03.001_bb0100","first-page":"19","article-title":"Desmopressin (DDAVP) for treatment of disorders of hemostasis","volume":"8","author":"Mannucci","year":"1986","journal-title":"Prog Hemost Thromb"},{"issue":"4","key":"10.1016\/j.blre.2014.03.001_bb0105","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF02215950","article-title":"Desmopressin (DDAVP) and hemostasis","volume":"69","author":"Lethagen","year":"1994","journal-title":"Ann Hematol"},{"key":"10.1016\/j.blre.2014.03.001_bb0110","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0079-6123(08)00437-8","article-title":"Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents","volume":"170","author":"Manning","year":"2008","journal-title":"Prog Brain Res"},{"issue":"7","key":"10.1016\/j.blre.2014.03.001_bb0115","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1182\/blood-2007-08-109231","article-title":"Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD","volume":"111","author":"Castaman","year":"2008","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.blre.2014.03.001_bb0120","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1182\/blood-2003-06-2072","article-title":"Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study","volume":"103","author":"Federici","year":"2004","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1016\/j.blre.2014.03.001_bb0125","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1538-7836.2009.03381.x","article-title":"Reduced von Willebrand factor survival in von Willebrand disease: pathophysiologic and clinical relevance","volume":"7","author":"Castaman","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2014.03.001_bb0130","series-title":"Ferring internal report 45A05\/PR\/79","article-title":"Desmopressin injection 15\u03bcg\/mL for subcutaneous administration in testing of patients with von Willebrand's disease and platelet dysfunction","author":"Schulman","year":"1989"},{"key":"10.1016\/j.blre.2014.03.001_bb0135","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0140-6736(84)91393-X","article-title":"Shortening of bleeding time by 1-deamino-8-d-arginine vasopressin in various bleeding disorders","volume":"1","author":"Kobrinsky","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2014.03.001_bb0140","series-title":"Ferring internal report 45A05\/PR\/91","article-title":"Subcutaneous administration of desmopressin shortens the prolonged bleeding time in patients with von Willebrand's desease and platelet functional defects","author":"Tengborn","year":"1989"},{"issue":"8","key":"10.1016\/j.blre.2014.03.001_bb0145","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/ajh.20940","article-title":"The use of desmopressin as a hemostatic agent: a concise review","volume":"82","author":"Franchini","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2014.03.001_bb0150","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF01727749","article-title":"The subcutaneous administration of the vasopressin analogue 1-desamino-8-d-arginine vasopressin in patients with von Willebrand's disease and hemophilia","volume":"62","author":"K\u00f6hler","year":"1984","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.blre.2014.03.001_bb0155","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/ajh.1058","article-title":"Retrospective review of the management of elective surgery with desmopressin and clotting factor concentrates in patients with von Willebrand disease","volume":"66","author":"Nitu-Whalley","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2014.03.001_bb0160","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0049-3848(88)90316-7","article-title":"Clinical evaluation of subcutaneously administered DDAVP","volume":"49","author":"Ghirardini","year":"1988","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2014.03.001_bb0165","first-page":"503","article-title":"The clinical significance of different routes of desmopressin (DDAVP) administration in various bleeding disorders","volume":"115","author":"M\u00f6rsdorf","year":"1988","journal-title":"Folia Haematol"},{"key":"10.1016\/j.blre.2014.03.001_bb0170","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000216097","article-title":"Subcutaneous injection of desmopressin (DDAVP): evaluation of a new, more concentrated preparation","volume":"1","author":"K\u00f6hler","year":"1989","journal-title":"Haemostasis"},{"key":"10.1016\/j.blre.2014.03.001_bb0175","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJM198301063080102","article-title":"Deamino-8-d-arginine vasopressin shortens the bleeding time in uremia","volume":"308","author":"Mannucci","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2014.03.001_bb0180","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ajh.2830310106","article-title":"Subcutaneous desmopressin (DDAVP) shortens the bleeding time in uremia","volume":"31","author":"Vigan\u00f2","year":"1989","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2014.03.001_bb0185","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/ncpneph0421","article-title":"Evidenced-based treatment recommendations for uremic bleeding","volume":"3","author":"Hedges","year":"2007","journal-title":"Nat Clin Pract"},{"key":"10.1016\/j.blre.2014.03.001_bb0190","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1182\/blood.V67.4.1148.1148","article-title":"Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time","volume":"67","author":"Mannucci","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.03.001_bb0195","first-page":"241","article-title":"Effects of desmopressin on hemostatis in patients with liver cirrhosis","volume":"25","author":"Agnelli","year":"1995","journal-title":"Haemostasis"},{"key":"10.1016\/j.blre.2014.03.001_bb0200","first-page":"59","article-title":"Hemostatic and hemodynamic effects of vasopressin analogue DDAVP in patients with cirrhosis","volume":"27","author":"L\u00f3pez","year":"1997","journal-title":"Acta Gastroenterol Latinoam"},{"key":"10.1016\/j.blre.2014.03.001_bb0205","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1136\/bmj.291.6506.1377","article-title":"Desmopressin and bleeding time in patients with cirrhosis","volume":"291","author":"Burroughs","year":"1985","journal-title":"Br Med J"},{"key":"10.1016\/j.blre.2014.03.001_bb0210","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1055\/s-0038-1647318","article-title":"Subcutaneous desmopressin (DDAVP) shortens the prolonged bleeding time in patients with liver cirrhosis","volume":"64","author":"Cattaneo","year":"1990","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2014.03.001_bb0215","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/hep.1840180514","article-title":"Randomized controlled trial of desmopressin plus terlipressin vs. terlipressin alone for the treatment of acute variceal hemorrhage in cirrhotic patients: a multicenter, double-blind study. New Italian Endoscopic Club","volume":"18","author":"de Franchis","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.blre.2014.03.001_bb0220","first-page":"177","article-title":"Pr\u00e4operative Identifikation von Patienten mit (prim\u00e4ren) H\u00e4mostasest\u00f6rungen \u2014 Ein praktisches Konzept","volume":"27","author":"Koscielny","year":"2007","journal-title":"Hamostaseologie"},{"issue":"3","key":"10.1016\/j.blre.2014.03.001_bb0225","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1055\/s-0037-1617035","article-title":"Patients with oral anticoagulation\u2014bridging anticoagulation in the perioperative phase","volume":"29","author":"Koscielny","year":"2009","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.blre.2014.03.001_bb0230","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s00113-010-1881-x","article-title":"Empfehlung f\u00fcr die Anwendung konventioneller und neuer Antithrombotika aus an\u00e4stesiologischer Sicht","volume":"11","author":"Gogarten","year":"2010","journal-title":"Unfallchirurg"},{"issue":"6","key":"10.1016\/j.blre.2014.03.001_bb0235","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1538-7836.2006.02001.x","article-title":"More on: platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function","volume":"4","author":"Koscielny","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1016\/j.blre.2014.03.001_bb0240","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s00101-007-1182-0","article-title":"Preoperative evaluation of the bleeding history. Recommendations of the working group on perioperative coagulation of the Austrian Society for Anaesthesia, Resuscitation and Intensive Care","volume":"56","author":"Pfanner","year":"2007","journal-title":"Anaesthesist"},{"issue":"3","key":"10.1016\/j.blre.2014.03.001_bb0245","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/107602960401000301","article-title":"A practical concept for preoperative identification of patients with impaired primary hemostasis","volume":"10","author":"Koscielny","year":"2004","journal-title":"Clin Appl Thromb Hemost"},{"issue":"2","key":"10.1016\/j.blre.2014.03.001_bb0250","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/107602960401000206","article-title":"A practical concept for preoperative management of patients with impaired primary hemostasis","volume":"10","author":"Koscielny","year":"2004","journal-title":"Clin Appl Thromb Hemost"},{"issue":"2011","key":"10.1016\/j.blre.2014.03.001_bb0255","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.athoracsur.2010.11.078","article-title":"Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines","volume":"91","author":"Ferraris","year":"2011","journal-title":"Ann Thorac Surg"},{"issue":"9","key":"10.1016\/j.blre.2014.03.001_bb0265","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1111\/j.1538-7836.2011.04432.x","article-title":"Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents","volume":"9","author":"Levi","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2014.03.001_bb0270","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001884.pub2","article-title":"Desmopressin use for minimising perioperative allogeneic blood transfusion","author":"Carless","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.blre.2014.03.001_bb0280","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0022-3476(89)80886-8","article-title":"Clinical experience with desmopressin: efficacy and safety in central diabetes insipidus and other conditions","volume":"114","author":"Harris","year":"1989","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.blre.2014.03.001_bb0285","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/(SICI)1096-8652(199802)57:2<153::AID-AJH11>3.0.CO;2-D","article-title":"Antidiuretic effect of desmopressin given in hemostatic dosages to healthy volunteers","volume":"57","author":"Lethagen","year":"1998","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2014.03.001_bb0290","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/j.seminhematol.2004.09.009","article-title":"von Willebrand factor and factor VIII as risk factors for arterial and venous thrombosis","volume":"42","author":"Martinelli","year":"2005","journal-title":"Semin Hematol"},{"key":"10.1016\/j.blre.2014.03.001_bb0295","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1055\/s-0038-1661458","article-title":"Comparative study of intranasal, subcutaneous and intravenous administration of desamino-d-arginine vasopressin (DDAVP)","volume":"55","author":"K\u00f6hler","year":"1986","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2014.03.001_bb0300","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00558266","article-title":"Pharmacokinetics and haematological effects of desmopressin","volume":"35","author":"K\u00f6hler","year":"1988","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.blre.2014.03.001_bb0310","series-title":"Internal Ferring report 45A05-119","article-title":"Antidiuretic effect of desmopressin given in hemostatic dosages to healthy volunteers","author":"Bengtsson","year":"1998"},{"key":"10.1016\/j.blre.2014.03.001_bb0315","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1034\/j.1600-0773.2003.920306.x","article-title":"Pharmacokinetics and antidiuretic effect of high-dose desmopressin in patients with chronic renal failure","volume":"92","author":"Ruzicka","year":"2003","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.blre.2014.03.001_bb0320","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(77)91469-6","article-title":"D.D.A.V.P. in haemophilia letter","volume":"310","author":"Lowe","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2014.03.001_bb0325","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(77)90537-2","article-title":"D.D.A.V.P. in haemophilia letter","volume":"310","author":"Ingram","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2014.03.001_bb0330","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1056\/NEJM198804073181403","article-title":"Hemodynamic and coagulation responses to 1-desamino8-d-arginine vasopressin in patients with congenital nephrogenic diabetes insipidus","volume":"318","author":"Bichet","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2014.03.001_bb0335","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2265.1986.tb03258.x","article-title":"Hormonal and cardiovascular responses to DDAVP in man","volume":"24","author":"Williams","year":"1986","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.blre.2014.03.001_bb0340","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0049-3848(88)90328-3","article-title":"Venous thromboembolism and transient thrombocytopenia in a patient with diabetes insipidus treated with desmopressin acetate (DDAVP)","volume":"50","author":"Albert","year":"1988","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2014.03.001_bb0345","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1056\/NEJM198801143180215","article-title":"Myocardial infarction in a patient with hemophilia treated with DDAVP","volume":"318","author":"Bond","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2014.03.001_bb0350","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ajh.2830280115","article-title":"Thrombosis following desmopressin for uremic bleeding","volume":"28","author":"Byrnes","year":"1988","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2014.03.001_bb0355","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0140-6736(89)92161-2","article-title":"Desmopressin and myocardial infarction letter","volume":"333","author":"O'Brien","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2014.03.001_bb0360","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0140-6736(89)92161-2","article-title":"Desmopressin and myocardial infarction letter","volume":"333","author":"van Dantzig","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2014.03.001_bb0365","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.thromres.2006.09.004","article-title":"Evaluation of the clinical safety of desmopressin during pregnancy in women with a low plasmatic von Willebrand factor level and bleeding history","volume":"120","author":"S\u00e1nchez-Luceros","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2014.03.001_bb0370","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00404-005-0739-x","article-title":"New approach of the treatment of von Willebrand's disease during pregnancy","volume":"273","author":"Gojnic","year":"2005","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.blre.2014.03.001_bb0375","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1182\/blood-2004-11-4472","article-title":"Use of desmopressin (DDAVP) during early pregnancy in factor VIII-deficient women","volume":"105","author":"Mannucci","year":"2005","journal-title":"Blood"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X14000277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X14000277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T18:10:37Z","timestamp":1597601437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X14000277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0268960X14000277"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2014.03.001","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Desmopressin in treatment of haematological disorders and in prevention of surgical bleeding","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2014.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}